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Abstract.  We demonstrate that the behavior of cells 
expressing v-src,  a tyrosine kinase oncogene, differs 
profoundly between the embryonic and culture en- 
vironments. V-src was introduced into avian embryo 
cells both in culture and in stage-24 embryo limbs, 
using replication-defective retroviral vectors.  These 
vectors were used as single-hit, cellular markers to 
determine the environmental influences imposed by 
normal cells and tissues on clonal cell growth. The 
marker gene lacZ was coexpressed with v-src in order 
to locate the descendent cells. In culture, v-src in- 
duced rapid morphological transformation and 
anchorage-independent growth of embryo fibroblasts; 
the vectors were also tumorigenic in hatchling 
chickens. In contrast, most of the cell clones express- 
ing v-src in the embryo grew normally without neopla- 
sia.  Expression of v-src vectors could be found in a 
wide range of cell types, demonstrating not only that 
neoplastic transformation is attenuated in ovo, but also 
that differentiation commitment in many lineages can 
be maintained concurrently with oncogene expression. 
Significantly, the embryonic control of cell growth 
could be perturbed by v-src under certain conditions. 
Rare, marked clones showed hyperplasia or dysplasia, 
and the primitive endothelium could succumb to rapid 
neoplasia; thus, these embryonic tissues are not inher- 
ently deficient in transformation factors. We propose 
that the environmental conditions imposed on cells in 
ovo are critical for the attenuation of neoplasia, while 
cultured cells lose this requisite environment. 
I 
T is widely accepted that proteins of the tyrosine kinase 
family play an important role in both carcinogenesis 
and embryonic development. The neoplastic transfor- 
mation of cultured ceils by activated tyrosine kinases is well 
established (for review see Bishop and Varmus,  1982), while 
critical roles for their endogenous counterparts in control- 
ling embryonic events are suggested by their fetal expres- 
sion,  and evolutionary conservation (Cotton and Brugge, 
1983;  Hoffman et al.,  1983;  Levy et al.,  1984;  for review 
see Muller,  1986).  The mechanisms of action of these pro- 
teins remain unclear, as do the reciprocal mechanisms for 
controlling their activities. Moreover, while the consequences 
of neoplastic and embryonic cell growth are quite different, 
it is known that traits such as migratory or invasive behavior, 
and continued growth at high cell density are common quali- 
ties (for review see Levine et al., 1984). Some of these traits 
may be related manifestations of  tyrosine kinase action, seen 
under different cell and developmental conditions. One might 
therefore predict that the cellular response to tyrosine kinase 
activation would vary significantly depending upon the cell's 
environmental context. To support this, there are documented 
examples showing that oncogenesis by tyrosine kinases may 
be subject to embryo- and differentiation-induced modula- 
tion (Birek et al., 1988;  Carmier and Samarut, 1986;  Dol- 
berg and Bissell, 1984; Milford and Duran-Reynals, 1943). 
Our past work has shown that expression of Rous sarcoma 
virus  (RSV) t is compatible with apparently normal myo- 
genic development in ovo (Dolberg and Bissell, 1984; How- 
lett et al., 1988). RSV is normally a highly oncogenic retro- 
virus in cultured cells and in animals, expressing the v-src 
oncogene and its tyrosine kinase product pp60  ..... (Brugge 
and Erikson,  1977; Martin,  1970;  Rous,  1911; for reviews 
see Teich et al., 1982, and Bishop and Varmus, 1982).  The 
lack of sarcoma response in ovo, despite expression of active 
pp60  ..... (Howlett et al., 1988),  suggests that v-src-embryo 
interactions  are  unusual.  However,  further  embryonic 
studies with RSV have been hindered by problems of re- 
stricted tissue tropism,  and lethal hemorrhagic disorders 
(Coates et al.,  1968;  Duran-Reynals, 1940;  Howlett et al., 
1987). A new approach is described which overcomes these 
problems,  permitting us to study clonal cell responses to 
v-src under conditions in culture and in numerous tissues in 
ovo. We can now address whether embryo ceils are intrinsi- 
cally nonresponsive to v-src action, or whether the tissue en- 
vironment in ovo imposes a dominant counteractive influ- 
ence over neoplastic stimuli. 
Replication-defective (rd)  retrovirus  vectors  were  used 
here to mark cells genetically, using the lacZ histochemical 
marker gene to trace their positional and behavioral fates. A 
1. Abbreviations  used in this paper: CEF, chicken embryo fibroblast; EFU, 
expression focus unit; rd, replication defective; RSV, Rous sarcoma virus. 
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cogene expression to individual ceils and their direct descen- 
dents. Such cell clones, grown in intimate contact with other 
cells and tissues, would be subject to the normal regulative 
interactions prevailing in the environment. We have focused 
upon expressing v-src in cultured chicken embryo fibroblasts 
(CEF), and cells within the chicken forelimb between day 4 
(embryonic stage 24; Hamburger and Hamilton,  1951) and 
day 14 of development. The limb was chosen as an apposite 
model of morphogenesis and cellular differentiation involv- 
ing such cells as myoblasts, chondroblasts, and fibroblasts 
which are susceptible to transformation by v-src under cul- 
ture conditions (Moss et al.,  1979;  Boettiger et al.,  1983; 
Pacifici et al.,  1977; Hinchliffe and Johnson, 1980). Our rd 
v-src vectors exhibited clear oncogenic properties in cul- 
tured embryo fibroblasts and in  chickens,  as expected. In 
contrast, cell clones expressing v-src in ovo exhibited normal 
growth regulation in many tissues, with a number of infor- 
mative exceptions including the induction of endothelial neo- 
plasia.  These data suggest mechanisms through which the 
environment can influence the developmental and oncogenic 
behavior of cells, and may shed light on critical cellular de- 
terminants of v-src action. 
Materials and Methods 
Construction of rd Retroviral Vectors 
Retroviral vector plasmid (prefix p) pCKlacl  was derived from an avian 
erythroblastosis virus-based vector lacking the internal v-erbA and v-erbB 
genes (pCK, a gift of B. Vennstrom and K. Khazaie, European Molecular 
Biology Laboratory, Heidelberg). A 3-kb Bam HI fragment containing bac- 
terial lacZ (obtained from pSP6-~gal, a gift from C. Cepko (Harvard Medi- 
cal  School),  containing lacZ  from pMC1871  [Price  et  al.,  1987])  was 
inserted into the 5' Bam HI site in residual gag  sequences. The ~-galac- 
tosidase protein encoded by lacZ is amino terminally fused to the first 52 
amino acids of viral gag. pBlacsrc2 was derived from pall, a proviral clone 
of a reverse-transcriptase defective B77 RSV (A gift of J.  Wyke,  Beatson 
Institute, Glasgow,  UK; Levantis et al.,  1986).  Structural gene sequences 
between positions 630 and 6,983  bp (Prague C  RSV reference sequence; 
Beveren et al., 1985) were removed, and the resulting plasmid (pAll-b) was 
digested with Barn HI  (position 530 bp); the lacZ gene was inserted as 
above. Vector Bsrc2 is a subgenomic derivative of Blacsrc2, created by viral 
transmission from packaging cells of spliced v-src mRNA (Stoker and Sie- 
weke, 1989). A molecular clone representing vector Bsre2 was constructed 
from pAl l-b and pAScre7  (a  subgenomic vector structurally  similar to 
Bsrc2; Stoker and Sieweke, 1989):  the Sstl-Ncot fragment (259-7,127  bp 
of RSV) was removed from pal 1-b and replaced with the 5' SstI-NcoI seg- 
ment from pASre7 containing the fused splice  junction. The resulting vector 
pBsrc2a is exactly representative of Bsrc2 except for a short segment de- 
rived from Rous-associated virus-1  (equivalent of 259-398 bp of RSV). 
Cells, Virus Production, and Virus Assays 
Viruses were obtained from the ASLV packaging cell line Q2bn after trans- 
fection with uncut vector plasmids (Stoker and Bissell, 1988).  Virus was 
assayed using either the immunocytochemical expression focus unit (EFU) 
procedure (Stoker and Bissell, 1987),  or histochemistry using 5-Bromo-4- 
Chloro-3-Indolyl ~-D-Galactopyranoside (Xgal).  CEFs  (obtained as de- 
scribed in Stoker and Bissell, 1988;  specific pathogen-free white leghorn 
embryos; Spafas, Inc., Norwich, CT) were infected after plating 4  ×  105 
cells per 35-mm plate. After 4 d the ceils were fixed in 2% paraformalde- 
hyde for 20 rain, and washed in PBS/0.1%  BSA/0.25% Triton X100, for 5 
rain.  EFU assays were performed using monoclonal anti-pp60  v','c as the 
primary antibody 0B327, a gift of J. Brugge, University of Pennsylvania, 
Philadelphia); the streptavidin-linked alkaline phosphatase (Zymed Labo- 
ratories, Inc., San Francisco, CA) was used at 1:2,000 dilution (Stoker and 
Bissell, 1987).  Xgal-treatment of infected CEF and tissues was performed 
as described by Price and co-workers (1987). Viruses (prefix rd) rdBlacsrc2 
and rdBsrc2 were transmitted concurrently from the packaging cells in a ra- 
tio of '~ 3:2, respectively; Blacsrc2 was stable for lacZ and v-src coexpres- 
sion; only 1-2 % of the derived virus was phenotypically lac[+lsrc[-]  (de- 
tails of these quantitation analyses will  be presented elsewhere; A.  W. 
Stoker, manuscript in preparation). Before injection into embryos, rd vi- 
ruses  were  concentrated  in  Centricon-30  microconcentrators  (Amicon 
Corp., Danvers, MA) at 5000 g for 30 min in an SS-34 rotor (Sorvall Instru- 
ments Div., Newton, CT) yielding a  10-20-fold increase in active virus 
titer. 
Soft Agar and Tumor Assays 
CEFs infected with viruses were seeded in soft agar (0.4%  final concentra- 
tion in medium 199 supplemented with 10% tryptose phosphate, 4% calf 
serum, 1% chicken serum). After incubation at 37°C for 9-14 d, the intact 
agar layer was fixed in 4% paraformaldehyde for 1 h, then treated with Xgal 
as above.  Tumorigenicity was assayed by injecting virus intramuscularly 
into the wing webs of day  5 hatchling chickens (White leghorn; Spafas, 
Inc.). Tumor nodules were removed and fixed in 4 % paraformaldehyde for 
1 h, followed by a 1-h wash in PBS, 0.1 M glycine, 0.25% Triton XI00. Tis- 
sues were treated with Xgal overnight. 
Limb Bud Injection and Whole Mount Histochemistry 
Virus was injected into day 4 limb buds (embryonic stage 24; Hamburger 
and Hamilton, 1951) as described previously (Dolberg and Bissell, 1984). 
Up to 500 viruses were injected per limb in a volume range of 0.1-0.5/zl. 
After further incubation, embryos were killed and limbs were fixed in 4% 
paraformaldehyde for 30 min (day 5-7 embryos) or 45-60 min (day  11-14 
embryos), followed by washing in PBS, 0.1 M glycine, 0.25% Triton X100 
for 30 min. Whole limbs were reacted with Xgal overnight at room tempera- 
ture. Tissues being prepared for immunofluorescence were not reacted with 
Xgal before cryosectioning. 
Cryosectioning and lmmunofluorescence 
Tissues with or without prior XgaI staining were equilibrated to 15 % fol- 
lowed by 30% sucrose in PBS before embedding in OCT compound (Miles 
Laboratories, Inc., Elkhart, IN) and freezing in liquid nitrogen. Frozen sec- 
tions (4-5 p.m) were made using a Leitz Kryostat 1720, and collected on 
gelatin-coated slides. Sections were stained histologically using Diff-Quik 
(American Scientific Products Div., McGaw Park, IL). For immunofluores- 
cence, serial sections were used from Xgal untreated tissues: sections were 
washed for 30 min in PBS, 0.5 % Triton, 0.1% BSA, followed by the primary 
anti-pp60  v-~'c  antibody (v-src (Ab-1) [affinity-purified  form of JB327],  1:10 
dilution; Oncogene Science, Manhasset, NY) added for 2 h at room temper- 
ature in PBS, 0.25% Triton,  1% BSA. After washing in PBS, 0.1% BSA, 
0.25%  Triton  for  1 h,  the secondary antibody (oiotinylated antimouse; 
Amersham Corp., Arlington Heights, IL, used at 1:50 dilution) was added 
for 1 h.  After washing as above,  the tertiary affinity layer (Streptavidin- 
conjugated Texas red, 1:100 dilution; Amersham Corp.) was added for 45 
rain,  followed by overnight washing at 4°C.  Sections were mounted in 
buffered glycerol  with  p-phenylenediamine (Sigma  Chemical  Co.,  St. 
Louis, MO), and photomicrographs were taken using a Zeiss Photomicro- 
scope III and  Ektachrome  film (Eastman Kodak  Co.,  Rochester,  NY); 
cibachromes were printed by ZIBA Color Lab. (Berkeley,  CA). Serial sec- 
tions of those used for immunofluorescence were reacted with Xgal over- 
night. 
Expression Assays for pp60  ~ 
35-mm plates containing 4  x  105 quail QT6 cells were transfected with 
circular plasmid using the calcium phosphate procedure (Graham and Van 
der Eb, 1973).  Either 0.4 or 0.8/~g of vector DNA was transfected per plate 
together with either 3.6 or 3.2 #g of pUC19 carrier DNA, respectively. Qua- 
druplicate plates were used per experiment. After 20 h, a pair of plates from 
each set was placed with methionine-free medium 199 for 1 h, then meta- 
bolically labeled for 3 h  with [35S]methionine  (Amersham Corp.). Cells 
were lysed in RIPA buffer and pp6@  'c was immunoprecipitated using ex- 
cess monoclonal 327  or  a  monoclonal raised  against  residues 2-17  of 
pp60  v-s'c (Hybridoma 203-7D10;  National Cancer Institute/Biological Car- 
cinogenesis Branch repository, Bethesda, MD). After polyacrylamide gel 
electrophoresis, the proteins were visualized using fluorography and pre- 
flashed film (X-Omat; Eastman Kodak Co.); intensities of pp60  v's'c bands 
were measured using scanning densitometry (Ultrascan densitometer/Inte- 
grator; Pharmacia LKB Biotechnology Inc., Piscataway,  NJ). The remain- 
ing pairs of plates were processed for Hilt DNA extraction as described in 
Arrigo et al. (1988).  Hirt DNA was digested to completion with restriction 
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Figure  L  Proviral  structures  of rd  vectors. 
Procedures for the construction of recombinant 
vectors are described in Materials and Meth- 
ods. CKlacl is the control, nononcogenic vec- 
tor. Blacsrc2 and Bsrc2 are derived from the 
unspliced and spliced RNAs, respectively, ex- 
pressed from pBlacsrc2 in the packaging cells 
(loss of intron sequence is indicated by dashed 
lines); both rdBlacsrc2 and rdBsrc2 are released 
concurrently from these cells, sa, sd, and sj, 
represent splice acceptor, donor, and junction, 
respectively. LTR represents viral long terminal 
repeat. Hatched boxes represent residual struc- 
tural gene sequences. Restriction sites (E) Eco 
RI; (B) Barn HI. 
enzyme Eco RI, and subjected to agarose gel electrophoresis.  DNA was 
transferred to nylon membranes (Hybond-N plus; Amersham Corp.), and 
hybridized to a 600 bp PstI v-src probe (8,054 to 8,666 bp of RSV) labeled 
by random priming with [32P]dCTP (Feinberg and Vogelstein, 1983)• Hy- 
bridized DNA was quantitated by scintillation counting. 
Results 
Construction and Characterization of rd Vectors 
rd retroviral vectors were constructed to provide an efficient 
means of gene transduction both into cultured cells and tis- 
sues in the embryo (Fig.  I). An important characteristic of 
these vectors was their ability to express the histochemical 
marker gene lacZ, encoding bacterial/3-galactosidase; vec- 
tor Blacsrc2 was also designed to coexpress the oncogene 
v-src. Infectious retroviruses were obtained after transfection 
of plasmid  vector  DNA  into  retroviral  packaging  cells 
(Stoker and Bissell, 1988). Significantly, expression of vec- 
tor Blacsrc2 in these cells caused the release of not only 
rdBlacsrc2, but also its subgenomic derivative virus, rdBsrc2 
(Fig. 1) (Stoker and Sieweke, 1989). Thus, it should be noted 
that in all studies using these viruses, a mixed population of 
rdBlacsrc2 and rdBsrc2 is used. The two vectors infect cells 
independently, and these cells can be identified by their dif- 
ferential  expression of lacZ and  pp60  .....  (see  below  and 
Materials and Methods). The titers of rdCKlacl, rdBlacsrc2, 
and rdBsrc2 ranged from 104-5  x  l@/ml before concentra- 
tion; titers up to l@/ml were obtained after concentration. 
Transforming Properties of rd Vectors in Culture 
To compare the behavior of cells expressing v-src under cul- 
ture and  embryonic conditions,  the  vectors Blacsrc2 and 
Bsrc2 were first introduced into CEF in monolayer culture. 
CEFs were infected with rd vectors and after 4 d the cells 
were treated with Xgal to visualize cells expressing Blacsrc2 
or CKlacl, followed by the immunocytochemical EFU assay 
to visualize those cells expressing pp60  v-s~ from Bsrc2 (see 
Materials and Methods). In this period the majority of cells 
expressing Blacsrc2 had formed distinct, well-transformed 
foci; the same being true for Bsrc2 (Fig. 2, A, B, and F). 
CEF infected with rdCKlacl remained morphologically in- 
distinguishable from uninfected cells (Fig.  2 E).  The sec- 
ond, and more stringent parameter of carcinogenicity tested, 
was cell growth in suspension media (Shin et al., 1975). Af- 
ter seeding in soft agar, CEF infected with rdBlacsrc2 and 
rdBsrc2 grew and formed compact colonies, whereas mock- 
infected CEF failed to grow. Approximately 75 % of  colonies 
reacted uniformly with Xgal,  indicating that Blacsrc2 in- 
duced suspension growth (Fig. 2 C); the remaining colonies 
were devoid of Xgal stain showing that Bsrc2 induces similar 
growth (Fig. 2 G). Significantly, the ratios of colonies induced 
by Blacsrc2 and Bsrc2 in agar were close to the frequencies 
of the two rd viruses (3:2); both vectors thus sustained sus- 
pension growth with similar efficiency. Furthermore, no sig- 
nificant differences were seen in the morphology or average 
sizes of colonies induced by RSV, Blacsrc2, or Bsrc2. Under 
culture conditions, therefore, these vectors are highly onco- 
genic. 
Oncogenicity of v-src Vectors in Hatchling Chickens 
As a further test of v-src vector carcinogenicity, rd viruses 
were injected intramuscularly into the wing webs of hatch- 
ling chickens. Tumor nodules were palpable 7 to 8 d after 
inoculation, and these could grow rapidly for several weeks 
(Fig.  2  H).  Tumors  formed in  nearly  100%  of injected 
chickens, with the lower limit of inoculation being approxi- 
mately one to two viruses (Fig. 2 H). Tissues removed 14- 
16 d after inoculation were stained with Xgal, revealing that 
focal growths of Xgal reactive cells, 0.5--4 mm in diameter, 
were  present  (Fig.  2  D).  The  Blacsrc2-induced  growths 
showed characteristics of fibrosarcomas by histology (data 
not shown).  80-90%  of tumor nodules did not react with 
Xgal,  and  Southern analysis  of tumor DNA  showed that 
Bsrc2  was  invariably present in  these  (not shown).  Both 
Blacsrc2 and Bsrc2 were therefore carcinogenic in hatchling 
chicken tissues, although the subgenomic vector Bsrc2 was 
more aggressive in this tumor assay.  This is in agreement 
with recent tumor studies performed with related rd vectors 
(Stoker and Sieweke,  1989). It is important to note that in 
Stoker et al. Embryonic Attenuation of v-src Oncogenesis  219 Figure 2. Oncogenic properties of rd vectors in culture and hatched chickens. (,4 and B) Transformed CEF foci expressing Blacsrc2 and 
stained with Xgal 4 d after infection. The background is a monolayer of uninfected, Xgal nonreactive CEE (C) Soft agar colony of CEF 
expressing Blacsrc2 14 d after seeding. Cells were stained intensely blue (appearing dark) with Xgal. (D) Small tumor nodule removed 
14 d after inoculation of wing tissue with rdBlacsrc2; the Xgal-stained tumor tissue is seen in whole mount. (E) Nontransformed CEF 
expressing CKlacl and stained with Xgal in monolayer culture 4 d after infection. (F) Transformed CEF focus expressing Bsrc2, im- 
munochemicaUy stained for pp60  v-'~ using the EFU assay (Stoker and Bissell, 1987). The cell monolayer had received prior treatment 
with Xgal and the ceils shown were nonreactive. (G) Soft agar colony of CEF expressing Bsrc2; nonreactive with Xgal. (H) Wing web 
tumor induced by rdBsrc2, growing at 2 mo after inoculation; approximately two viruses had been injected. This tumor was clonal, contain- 
ing a single proviral copy of Bsrc2 (A. W. Stoker, unpublished data).  Bars: (D) 0.4 mm; (A-G same scale) 0.1 mm; (H) 1 crn. 
hatched chickens the target cells for v-src carcinogenesis are 
as yet undefined. 
Cell Lineage Marking In Ovo with a Control rd Vector 
Having determined the neoplastic response of cultured cells 
to v-src, the comparative response of embryo limb cells in 
ovo was examined. The first stage of this analysis involved 
injecting  stage  24  limb  primordia  with  the  control virus 
rdCKlacl, to determine both the range of infectable progeni- 
tor cell types, and their normal growth characteristics. Limbs 
were allowed to develop after injection and were next exam- 
ined at days 11-14 of development. To detect the descendents 
of infected progenitor cells,  limbs  were treated  in  whole 
mount with Xgal. Marked cells were located readily in this 
way (Fig. 3). 1-20 clusters of marked cells were observed in 
each limb,  occurring predominantly in the lower arm and 
wrist regions. Histologically, these clusters were usually of 
a single cell type, thus, although strict clonality could not be 
proven it was considered probable in most cases.  Marked 
cell clones were located predominantly within mesenchymal 
tissues, including the dermis, loose connective tissues, peri- 
chondrium,  periosteum,  and cartilage (Fig.  3,  C and D). 
CKlacl-expressing cells  were also  located  within  skeletal 
muscle blocks, although here the possible cell types which 
were marked, e.g., myotubes, myogenic satellite cells, or the 
perimesium, were not determined unequivocally. Epidermal 
clones were observed in both the inner,  basal  layers, and 
more frequently in the outer, peridermal layers (Fig. 3, A and 
B).  All marked clones were incorporated into the normal 
cytostructure of tissues.  These data demonstrate the utility 
of this clonal cell marking technique, and in particular the 
ability of rd viruses to infect progenitors of, and be expressed 
within,  a broad range of cell lineages in the embryo. 
To determine whether expression of vector-encoded genes 
initiated soon after their introduction in ovo, rdCKlacl  ex- 
pression was examined 9 and 19 h after injection of  the virus. 
By 9 h,  individual Xgal-reactive cells could be seen in the 
limb appendage, and by 19 h marked cells were distinguish- 
able in both ectodermal and mesenchymal compartments, 
some already present as sister-paired cells (data not shown). 
rd vectors thus act as generalized markers of embryo cells 
with rapid onset of expression. 
Normal Embryonic Cell Growth with Concurrent 
Expression of v-src 
rd v-src vectors were introduced into day 4 embryo limbs as 
described for CKlacl above. Cell clones expressing the vec- 
tors were later detected through their reactivity with Xgal 
The Journal of Cell Biology, Volume 111,  1990  220 Figure 3. Whole mount and cryosection analyses of cells expressing CKlacl  in day 12 embryo limbs. Vector CKlacl  was introduced into 
limb buds by injection of rd virus at stage 24 of development. Whole mount staining of injected limbs at day 12 of development shows 
the blue Xgal reaction product in expressing cells (A and C). The detailed cytostructure  of expressing tissues is seen in cryosections (B 
and D; Nomarski optics). (A) CKlacl-marked clone of epidermal cells extending onto a feather germ (f). (B) A 5-#m section of the tissue 
in A, showing the peridermal location of marked cells, e, Epidermis; d, dermis;f, feather germ. (C) CKlacl-marked cells within the mesen- 
chymal core of a feather filament (white arrow).  (D) CKlacl-marked  clone of cells embedded  in cartilage tissue.  Bars:  (A and C same 
scale)  100/zm;  (B and D same scale)  10/~m. 
and  expression  of pp60  ~-,''. Most  information  was  gained 
from cells expressing Blacsrc2, due to the ease with which 
numerous  independent  clones  could  be  identified  in  both 
whole mount and  sectioned tissues;  over 130  such clones 
were identified. At day 12-14 of development Xgal-reactive 
cells were located within connective tissues, skeletal muscle 
regions, capillary endothelium, perichondrium, periosteum, 
cartilage, and ectoderm (Fig. 4). The range of mesenchymal 
tissues was similar to that seen with CKlacl, indicating that 
Blacsrc2 did not significantly alter the developmental fate or 
viability of diverse lineages. With few exceptions the histol- 
ogy and clone sizes of cells expressing Blacsrc2 were com- 
parable to those seen using the control vector. Clear exam- 
ples of this regulated clonal growth were seen in the periderm 
(of ectodermal origin) (Fig. 4, A and B; comparable clone 
seen in Fig. 3, A and B), and the mesenchymal core of feather 
filaments (Fig. 4,  C and D; comparable clone seen in Fig. 
3  C).  Numerous examples of normal cartilage clones em- 
bedded  in collagenous matrix were found (Fig.  4  E;  com- 
parable clone seen in Fig.  3 D),  in addition  to endothelial 
cells within capillaries (Fig. 4, F  and G). 
The  coexpression  of  v-src  from  Blacsrc2  in  ovo  was 
confirmed using indirect immunofluorescence analysis of the 
oncoprotein pp60  V-~''. As the available procedures precluded 
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serial  sectioning  was performed  on  Xgal-untreated  tissues 
instead,  followed by screens for/~-gal and pp60  V-~'r"  in neigh- 
boring  sections.  Approximately  75 %  of the  xgal  reactive 
clones clearly coexpressed pp60  v-'r'', either in the same cell 
when seen in an adjacent section (Fig.  5, A/and A2), or in 
neighboring cells of the same marked clone (Fig.  5, A3-6). 
pp60  v-st' localization was apparent in both the plasma mem- 
brane and cytoplasm of cells, and again all tissues expressing 
pp60  v-s~' were  histologically  normal.  In the  remaining  25% 
of clones pp60  ..... expression was faint or undetectable using 
immunofluorescence.  No specific antibody  staining  was de- 
tected  in uninfected  tissues. 
In these same immunofluorescence studies, cell clones ex- 
pressing  vector Bsrc2  were  also  identified.  These  were  lo- 
cated through their expression of pp60  .... and complete non- 
reactivity with Xgal. To date these have been identified within 
the perichondrium, periosteum/osteoblast tissues, and muscle 
(Fig. 5 B), although this list of cell types is unlikely to be ex- 
clusive. As with Blacsrc2, these examples of Bsrc2 expression 
again coincided  with normal clonal histology  in the context 
of their  surrounding  tissues. 
Conditional Disturbance of CeU Growth In Ovo 
Caused by v-src 
The predominant response of embryonic tissues to v-src ap- 
peared  to be that of normal  growth  regulation.  Unless  the 
embryonic environment were absolutely  refractory to v-src 
oncogenesis, one would expect to see some exceptions to this 
growth control under specific circumstances.  Two examples 
of clones marked with Blacsrc2 were identified, one epider- 
Figure 5. Expression of pp60  .... in histologically normal tissues of 
day 12 limbs. (A) Coexpression of lacZ and pp60  v-'= in Blacsrc2- 
marked cell clones.  Injected limbs were sectioned at day 12 and 
serial sections were either treated with Xgal or processed for im- 
munofluorescence. (1, 3, and 5; Nomarski optics) Xgal-treated fro- 
zen sections showing the marked cells in center field (arrows). (2, 
4,  and  6)  Indirect immunofluorescence detection of pp60  v-'~. (I 
and 2) The same marked cell is seen in serial sections in cartilage 
tissue.  (3  and  4)  Sections  (nonserial)  of  osteoblast/osteocyte- 
containing tissue showing nearby cells of one marked clone, react- 
ing with Xgal (3) and expressing pp60  v-s= (4). (5 and 6) Adjacent 
cells of a  single marked clone within fibrous tissue (f) next to a 
muscle  primordium  (m).  (B)  Expression  of pp60  ....  in  Bsrc2- 
marked cells. (1 and 3) Diff-Quik-stained sections of day 12 limb 
tissues, c, Cartilage; Pc, perichondrium; Po, periosteum; o, osteo- 
blasts;  Ca, calcifying matrix.  (2 and 4) Indirect immunofluores- 
cence detection of pp6&  -'¢ in sections directly adjacent to those in 
1 and 3, respectively; the tissues were not reactive with Xgal. Bars, 
20 ~m. 
Figure 4.  Expression of Blacsrc2 in nonneoplastic limb tissues. Blacsrc2 was introduced into limb buds by injection of rd virus at stage 
24 of development. (A and B) Cells expressing Blacsrc2 seen in the periderm (p) of a day 14 feather filament (]'), in whole mount (A) 
and in cryosection (B; Nomarski optics).  (C and D) Blacsrc2-marked cells in the mesenchymal pulp of a day 14 feather filament (f) in 
whole mount (C) and in cryosection (D; Nomarski optics). The epidermal lobes of barbule tissue (b) are clearly delineated. (E) Blacsrc2- 
marked cells in day 12 cartilage tissues, embedded within collagenous matrix (Diff-Quik counterstain).  (F and G) Blacsrc2 expression 
in endothelial cells of a day  12 capillary (arrowheads), seen before (F) and after (G) Diff-Quik counterstaining.  Bars:  (,4 and  C same 
scale)  100 tLm; (B and D-G same scale)  10 ~tm. 
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by v-src in ovo. (A-D)  Limb 
primordia  were  injected  at 
stage 24 with rdBlacsrc2, and 
tissues were stained with Xgal 
at day 13 (,4 and B) or day 11 
(C and D). (.4 and B) Nearby 
sections through a single epi- 
dermal clone of cells express- 
ing Blacsrc2. Normal epider- 
mal cells in the stratifying  layer 
were seen in this clone (white 
arrow, A), as well as hyper- 
plastic regions (B). (Cand D) 
Nearby sections through a sin- 
gle chondrocytic  clone marked 
with  Blacsrc2.  Normal  cells 
in this clone were present in 
isolated lacunae (arrow, C), 
together with neighboring ab- 
normal subpopulations in en- 
larged, matrix-depleted lacu- 
nae  (D).  (E and  F)  Whole 
mount day 11 limbs. (A) Un- 
injected  normal limb. (B) Limb 
previously  injected  with  rd 
v-src viruses at embryo stage 
24, showing discrete vascular 
lesions in the lower arm and 
wrist regions. Bars: (A-D) 80 
t~m; (E and F) 0.25 cm. 
maI and the other chondrocytic, in which part of the-clone 
was normal and the rest clearly abnormal. The first example, 
an epidermal clone in the thumb,  was identified as having 
regions of both normal stratifying epidermal cells (Fig. 6 A), 
and patches of localized hyperplasia or dysplasia (Fig. 6 B). 
A heterogeneous chondrocytic clone was also found which, 
similarly, consisted of both normal cells in isolated cartilage 
lacunae (Fig. 6  C), and groups of atypical cells occupying 
enlarged lacunae devoid of matrix (Fig. 6 D). Localized dis- 
turbance in cell growth and/or differentiation had therefore 
been induced by v-src  in  these rare  instances  during this 
period of embryonic development. 
Two further kinds of growth disturbance were observed. 
Firstly, a minority of limbs (<20%) contained single local- 
ized regions of abnormal mesenchymal tissue (not reactive 
with Xgal;  data  not  shown).  These abnormalities did not 
conform to any consistent histological pattern and their tis- 
sues of origin could not be determined. In the second case, 
a frequent and highly consistent pattern of overt neoplasia 
was seen. Approximately 60% of limbs injected with v-src 
vectors contained macroscopic vascular lesions, first visible 
5 d after injection (Fig. 6, E and F, and 7 A). Lesions were 
not observed in limbs injected with either media or rdCKlacl. 
Histologically, the lesions were blood-filled cysts lined with 
layers of normal and/or neoplastic (epithelioid) endothelial 
tissue (Fig.  7, A and  C);  neoplastic cells were frequently 
contiguous with normal endothelium and cysts were directly 
associated with invasive neoplastic tissue. The poorly differ- 
entiated nature of tumor tissue was confirmed by the low and 
often undetectable levels of  the endothelial marker, Von Wille- 
brand factor (data not shown). Histological studies suggest 
that  growth  of the  endothelium became abnormal  within 
3-4 d of vector introduction, leading to cyst formation and 
tumor growth  into  interstitial  spaces.  The histopathology 
bore a  resemblance to hemangioma or hemangiosarcoma, 
possibly  representing the early embryonic counterpart of 
these neoplasms. The tumors were similar to those observed 
in transgenic mice strains carrying the polyoma middle T on- 
cogene (Bautch et al.,  1987;  Williams et al.,  1988). 
The vascular lesion tissue showed extensive expression of 
pp60  ......  , confirming the direct involvement of the oncopro- 
tein. pp60  ..... exhibited prominent plasma membrane asso- 
ciation in many tumor cells, forming a sharp interface with 
the underlying, pp60  .....  negative stromal tissue (Fig.  7, B 
and D). Further immunofluorescence studies did not reveal 
any helper virus p19~o~ proteins in vascular lesions (data not 
shown).  Interestingly, Xgal-reactive endothelial cells were 
rarely associated with vascular lesions, and only then in scat- 
tered patches of cells (not shown). Thus, although cells ex- 
pressing Blacsrc2 may occasionally be involved in lesion eti- 
ology, the majority of the tumors were initiated by individual 
cell clones expressing Bsrc2. Having characterized the cause 
The Journal of Cell Biology,  Volume 111, 1990  224 Figure  7.  Histology  and  pp60  v-'" immunofluorescence  analysis of vascular  lesions.  Histological  analysis  (.4 and  C) and  indirect  im- 
munofluorescence detection of pp60 V-'" (B and D) in a day 12 limb containing a cystic vascular lesion. The limb had been inoculated at 
stage 24 with rd v-src viruses. The tissues of  this lesion were not reactive with Xgal. (A) Diff-Quik-stained section showing the blood-filled 
lesion (hi) lined by endothelial tumor cells (0, and spurs of tumor tissue (open arrowhead). The lesion is flanked by normal muscle primor- 
dia (m), and the ulna (u). (B) pp60 V-" expression in endothelial tumor cells lining the lesion; cells are flanked by blood (bl) and a sharp 
interface (arrow) with pp60v"~-negative muscle tissues (m). (C) Enlargement of tumor area similar to that marked as t in A. Basophilic 
tumor cells are seen flanking the erythrocyte-filled cyst. (D) Serial section adjacent to C, showing pp60  ..... expression in the tumor tissue 
lining the lesion (bl). Strong pp60  V-s" signal is seen particularly  at cell-cell interfaces (arrow). The lack of sharp interface with underly- 
ing tissues reflects their invasion by tumor cells (contrasts with noninvasive tissue in B). The bright spherical cells seen at lower left are 
granuiocytes which nonspecifically bind the biotin-streptavidin reagents (irrespective of primary antibody used); such cells were often as- 
sociated with tumor tissues.  Bars: (A) 0.4 mm; (B-D same scale) 40 #m. 
of these vascular cysts, it is now apparent that the hemor- 
rhagic disease caused by RSV probably arises from a  sys- 
temic  form of this  endothelial  neoplasia  (Duran-Reynals, 
1940;  Coates et al.,  1968). 
Differential Expression of  pp60  ~  as a Possible 
Determinant of Vascular Oncogenesis 
One factor underlying the different tumorigenic potency of 
Blacsrc2 and Bsrc2 in endothelial cells, may be differential 
expression levels of pp6@  -s'~. To begin addressing this, ex- 
pression  of  pp60  .....  was  assayed  in  transfected  cultured 
cells, after a plasmid clone of vector Bsrc2 had been con- 
structed  (vector pBsrc2a;  see Materials  and Methods).  In 
ovo, vector Bsrc2a gave rise to vascular tumors identical to 
those seen with Bsrc2 (A. W. Stoker, data not shown). Using 
pBlacsrc2  and  pBsrc2a,  the  relative  expression  levels  of 
ppt0*  .... were measured after transient expression in trans- 
fected quail QT6 cells (Fig.  8 A). In addition,  our original 
clone of B77  RSV,  pall  (reverse transcriptase defective), 
was used for comparison. After correcting for low levels of 
coprecipitated pp60  ....  (Fig.  8  A,  lane QT6),  the pp60  ..... 
levels were normalized for transfection efficiency using the 
plasmid DNA levels in Hirt extracts from parallel cell plates 
(Fig.  8 B; see Materials and Methods). 
The data reveal high expression levels of the oncoprotein 
from both rd  vectors,  with  Bsrc2a  expressing on average 
50%  more  pp60  .....  than  Blacsrc2  (Fig.  8  C).  The  RSV 
clone, pal 1, expressed two to three times more oncoprotein 
than either vector in these assays. The relative elevation in 
pp60  v  ....  expression  from Bsrc2(a),  if reiterated  under  in 
ovo conditions, may explain in part why this vector, and not 
Blacsrc2, induces rapid endothelial neoplasia in ovo. Possi- 
ble factors such as restricted splicing of Blacsrc2 RNA in en- 
dothelial cells, may further differentiate these vectors, and 
this is presently under study. 
Discussion 
We  have  examined  the  influence  of cellular  environment 
upon oncogenesis, after transducing v-src into cells both in 
culture and in the embryo. Our approach of using rd vectors 
has a number of significant benefits. Firstly, expression of the 
Stoker et al. Embryonic Attenuation  of v-src Oncogenesis  225 Figure  8.  Relative pp60  V.'~ expression from retroviral v-src  vec- 
tors. (A) Fluorograph of a polyacrylamide gel containing immuno- 
precipitated pp60  v-~r'. Vector plasmids pBlacsrc2,  pBsrc2a,  and 
pAl 1 were transfected into QT6 cells and [35S]methionine-labeled 
pp60  v-~ was immunoprecipitated with mAb. Lane QT6 is a con- 
trol sample of QT6 cells transfected with pUC19 only; a faint band 
of pp61Y  -s~ is  present.  Protein  molecular  masses in  kD  are  at 
right. (B) Autoradiograph of a Southern transfer, containing Hirt 
DNA hybridized with a v-src probe. Hirt DNA was extracted from 
duplicate plates of QT6 cells to those used in A, and the DNA was 
subjected to Southern analysis after digestion with enzyme Eco RI. 
Molecular weights in kbp are at right. (C) The values represent rel- 
ative pp60  v-~ expression  levels from  pBlacsrc2,  pBsrc2a,  and 
pal 1. The amounts of pp60  ~-~'~ in A were first normalized to the 
respective transfection efficiency  calculated from the hybridization 
in B (see Materials and Methods). The value for Blacsrc2 is taken 
arbitrarily as 1.0. Each value is the average of two independent ex- 
periments. 
oncogene was restricted to independent clones of ceils in in- 
tegral  association  with  normal  cells  and  tissues,  thereby 
providing unperturbed conditions for environmental regula- 
tion. This may be a more accurate approach than is available, 
for example, in murine transgenic models where the environ- 
ment is potentially disturbed by transgene expression in en- 
tire tissues. A second advantage is that vectors can carry a 
marker gene together with the oncogene, facilitating the pre- 
cise localization of oncogene-expressing cells and resolu- 
tion of their clonal growth behavior.  The third advantage 
demonstrated here is the ability of rd vectors to mark a wide 
range of cell lineages, contrasting with the apparent myo- 
genic  tropism  of replication-competent RSV  (Howlett  et 
al., 1987); the prominent expression of RSV in muscle prob- 
ably reflects preferential viral spread in the tissue. A  final 
benefit of using rd vectors is the prevention of systemic viral 
disease. Specifically, the lethal hemorrhagic disease of RSV 
is avoided, significantly increasing embryo longevity. A po- 
tential drawback in this and other in vivo model systems is 
the  uncertainty  of transgene  expression  levels.  Although 
immunodetection of transgene products is sensitive, it is not 
straightforward to quantify. Given this caveat, however, we 
believe that  pp60  v-s~ expression  levels  in  ovo differ little 
from those found in cultured cells; no reproducible differ- 
ences have been observed at the immunofluorescence level 
(A. W. Stoker, unpublished observations), and rd vector ex- 
pression is similar both in ovo and in culture, as judged by 
lacZ  expression. 
By analyzing more than 100 independent transductions of 
v-src into a range of tissue progenitors, we gained broad in- 
sight into diverse environmental influences, and the possible 
effects of v-src  on differentiation patterns.  Our data  show 
v-src having little influence over the differentiation commit- 
ment or growth patterns of several lineages in the limb dur- 
ing the period examined, unlike the rapid neoplastic trans- 
formation of cultured CEE Similar transformation was seen 
in culture after introducing rd  v-src  vectors into differen- 
tiated embryo tendon cells (A. W.  Stoker and R. Schwarz, 
unpublished observations;  see also Schwarz et al.,  1978). 
Using RSV, others have demonstrated previously that v-src 
causes  rapid  loss  of growth regulation and  differentiation 
characteristics in other types of cultured embryo cell (Boet- 
tiger et al.,  1983; Ephrussi and Temin, 1960; Moss et al., 
1979; Pacifici et al., 1977; Pessac and Calothy, 1974). There 
could be several explanations for the embryo-culture dispar- 
ity. Cells are frequently altered biochemically and behavior- 
ally upon their transfer to culture, and there can be weakened 
maintenance of the differentiated state (Lee et al., 1984; for 
reviews see Bissell, 1981, and Bisell and Hall,  1987). Such 
changes may predispose cultured cells to perturbation by on- 
cogenes.  Interestingly,  differentiated "revertant" myotubes 
can occasionally arise from RSV-transformed myoblasts, sug- 
gesting that differentiation may override  v-src oncogenesis in 
culture under certain conditions (Tato et al.,  1983). 
Cells in culture may aberrantly express effectors of v-src 
action or cofactors required for transformation, whereas in 
ovo they do not.  The expression of one pp60  ..... substrate, 
p36, or calpactin, is indeed restricted in the embryo limb, but 
is  expressed  rapidly  upon  placing  limb  cells  in  culture 
(Carter et al., 1986). Although p36 has no known role in cell 
transformation, its expression may be indicative of more crit- 
ical targets which are induced upon culturing. Recent work 
in our laboratory has also implicated transforming growth 
factor ~ as a cofactor in RSV tumorigenesis in chickens (Sie- 
weke et al.,  1990); it is plausible that similar factors may 
exhibit differential expression in the embryo, affecting onco- 
genie permissiveness. Our present data nevertheless demon- 
strate that latent permissiveness towards cell transformation 
does exist in the embryo (Figs. 6 and 7). This is seen clearly 
in the embryonic endothelium, where overt neoplasia can be 
induced, and also in less frequent growth abnormalities of 
cartilage and epithelia. Thus, an inherent deficiency of trans- 
formation cofactors in ovo is now considered unlikely in sev- 
eral tissues; our data instead strongly implicate some aspect(s) 
of the embryonic tissue environment in  attenuating onco- 
genesis. 
The environmental influences governing cell growth, dif- 
ferentiation, and morphogenesis during limb development 
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in resisting v-src neoplasia. The extracellular matrix is im- 
plicated in maintaining differentiated function in cells (Blum 
et al., 1987; Bissell et al., 1987; Li et al., 1987; for review 
see Bissell and Hall, 1987), and in governing many processes 
during development (for reviews see Hay,  1984;  Thiery et 
al., 1989). Interestingly, significant  differences have recently 
been identified in the levels and organization of extracellular 
matrix components of cells in vivo and those cultured on 
plastic (Streuli and Bissell,  1990).  This may contribute to 
environmentally-conditioned  cellular responses to oncogene 
expression. A second factor integral to embryonic processes 
is junctional communication between cells (Fraser,  1985). 
Significantly, gap junction communication with normal cells 
is also known to suppress tumor cell growth both in vivo and 
in culture (Dotto et al., 1988; La Rocca et al., 1989; Mehta 
et al., 1986; Podesta et al., 1984; Stoker et al., 1966). Little 
evidence for similar suppression of cells expressing  pp60  ..... 
has been found to date, however (Bignami et al.,  1988; La 
Rocca, 1989; Weiss, 1970),  and detailed embryonic studies 
have not been reported with this oncogene. With this rd vec- 
tor model we show that cells expressing v-src can be subject 
to potential suppressive influences in tissues, the basis of 
which can now be examined. 
What  intracellular  mechanisms could  translate  the  en- 
vironmental state into abrogation of, or tolerance to v-src 
action? Cellular tyrosine kinases such as c-src and c-abl are 
expressed at elevated levels in several tissues during embryo- 
genesis, and are presumably biochemically active (Cotton 
and Brugge,  1983;  Levy et al.,  1984;  Muller,  1986).  It is 
likely, therefore, that kinase signal pathways are also active, 
and that concurrent expression of specific tyrosine protein 
phosphatases occurs (for reviews  see Hunter, 1989;  Lau et 
al.,  1989;  Tonks and Charbonneau, 1989).  Tyrosine phos- 
phorylation signal pathways that are active specifically in the 
embryo, may tolerate v-src action without disturbance to cell 
behavior.  Relatedly, phosphatases  which  may be  critical 
regulators in embryonic tyrosine phosphorylation pathways, 
could interfere with the potentially disruptive kinase action 
of pp60  v-'re. However,  both the signal pathways and the ex- 
pression of phosphatases may be disrupted upon culturing 
embryonic cells, allowing the oncogene to subvert cell growth 
control. 
The endothelial neoplasia caused by v-src,  and the en- 
dotheliomas induced by polyoma middle T  oncogene, are 
strikingly similar  (Bautch  et  al.,  1987; Williams  et  al., 
1988).  These endothelial neoplasias may arise by a related 
mechanism, since one prerequisite for middle T oncogenesis 
is its ability to bind and activate the pp60  ~s~ tyrosine kinase 
(Bolen et al., 1984; Courtneidge and Smith, 1984). Further- 
more, the similarity between rd vascular tumors and the le- 
thal hemorrhagic disease caused by RSV, signifies their com- 
mon origin as endothelial neoplasms. This sensitivity of the 
endothelium towards neoplasia indicates that it may harbor 
specific cofactors for transformation, or its unique vascular 
environment predisposes it to oncogenesis. Of interest are 
the elevated endogenous phosphotyrosine levels found in en- 
dothelial tissues of normal embryo limb (Howlett et al., 
1988;  Takata and Singer,  1988).  The differing endothelial 
tumorigenicity  of  Blacsrc2  and  Bsrc2  may  arise  from 
differential levels of pp60  .... expression, but this remains to 
be fully explained. 
Finally, the rare growth disturbances caused by Blacsrc2 
in  ovo  are  informative.  The  heterogeneity within certain 
clones,  resulting in both normal and aberrant subpopula- 
tions, suggests that secondary events in certain cells occur. 
These are more likely to be epigenetic changes than primary 
genetic mutations in  this time period  (7-9  d  of growth). 
Changes such as increases in pp60  v-~ expression, or reduced 
tolerance to existing oncoprotein levels, would remain con- 
sistent with there normally being a high basal resistance to 
growth perturbation. 
In summary, we have established that v-src expression in 
diverse lineages does not lead to neoplasia in ovo, and that 
these cells can maintain their commitment towards differen- 
tiation. This contrasts with cells under culture conditions 
where v-src oncogenesis occurs readily. An apparent excep- 
tion is seen in embryonic endothelia, which can be subject 
to rapid, v-src-induced neoplasia in ovo. Although the gen- 
eral resistance to v-src oncogenesis in ovo is not fully under- 
stood, our data suggest that it is largely due to the unique 
cellular environment of the embryo. We have proposed sev- 
eral feasible mechanisms, and our new model system will be 
of value in testing these. Such studies will enhance our un- 
derstanding of the cellular microenvironment as a control- 
ling influence over carcinogenesis and embryo development, 
and  will  shed  light on  the  requisite  cofactors  for  v-src- 
induced neoplasia. 
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